[1] Tsukada Y, Fang J, Erdjument-Bromage H, et al. Histone demethylation by a family of JmjC domain-containing proteins[J]. Nature, 2006, 439(7078):811-816.
[2] Martin C, Zhang Y. The diverse functions of histone lysine methylation[J]. Nature Reviews Molecular Cell Biology, 2005, 6(11):838-849.
[3] 冯 兵,朱 莹,贺嵩敏,等. 罗勒多糖对缺氧条件下肝癌细胞组蛋白H3K9me2甲基化及G9a、JMJD1A表达的影响[J]. 中药材, 2015, 38(7): 1460-1465.
[4] Cho H S, Toyokawa G, Daigo Y, et al. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G[J]. International Journal of Cancer, 2012, 131(3):E179-E189.
[5] Klose R J, Yamane K, Bae Y, et al. The transcriptional repressor JHDM3A demethylatestrimethyl histone H3 lysine 9 and lysine 36[J]. Nature, 2006, 442(7100):312-316.
[6] Garciabassets I, Kwon Y S, Telese F, et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors[J]. Cell, 2007, 128(3):505-518.
[7] Pedanou V E, Stéphane G, Sébastien T, et al. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L[J]. Elife, 2016, 5(2016):e16844-e16860.
[8] 彭文培,曾长军. 精子发生及冷冻过程中表观遗传调控的研究进展[J]. 中国畜牧兽医, 2014, 41(9): 199-205.
[9] Okada Y, Scott G, Ray M K, et al. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis[J]. Nature, 2007, 450(7166):119-123.
[10] Javadirad S M, Hojati Z, Ghaedi K, et al. Expression ratio of histone demethylase KDM3A to protamine-1 mRNA is predictive of successful testicular sperm extraction in men with obstructive and non-obstructive azoospermia[J]. Andrology, 2016, 4(3):492-499.
[11] Tateishi K, Okada Y, Kallin E M, et al. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance[J]. Nature, 2009, 458(7239):757-761.
[12] Ko S Y, Kang H Y, Lee H S, et al. Identification of Jmjd1a as a STAT3 downstream gene in mES cells[J]. Cell Structure & Function, 2006, 31(2):53-62.
[13] Ma D K, Chiang C H, Ponnusamy K, et al. G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells[J]. Stem Cells, 2008, 26(8):2131-2141.
[14] Beyer S, Kristensen M M, Jensen K S, et al. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF[J]. Journal of Biological Chemistry, 2008, 283(52):36542-36552.
[15] Chakraborty D, Wei C, Rosario G X, et al. HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia[J]. Proc Natl Acad Sci USA, 2016,113(46):E7212-E7221.
[16] Fan L, Peng G, Sahgal N, et al. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival[J]. Oncogene, 2015, 75(15 Supplement):2441-2452.
[17] Pa M, Naizaer G, Seyiti A, et al. KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer[J]. Journal of Molecular Histology, 2016, 46(2):511-518.
[18] Justin N, De M V, Aasland R, et al. Reading, writing and editing methylated lysines on histone tails: New insights from recent structural studies[J]. Current Opinion in Structural Biology, 2010, 20(6):730-738.
[19] Knebel J, Haro L D, Janknecht R. Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71[J]. Journal of Cellular Biochemistry, 2006, 99(1):319-329.
[20] Yang H, Liu Z, Yuan C, et al. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer[J]. International Journal of Clinical & Experimental Pathology, 2015, 8(9):11092-11099.
[21] Park S Y, Park J W, Chun Y S. Jumonji histone demethylases as emerging therapeutic targets[J]. Pharmacological Research, 2016, 105:146-151.
[22] Parrish J K, Sechler M, Winn R A, et al. The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma[J]. Oncogene, 2015, 34(2):257-262.
[23] Hoghoughi N, Hojati Z. Study of the relation between rs11677451 and rs 2030259 polymorphic markers in Jhdm2a gene and male infertility[J]. Cell Journal (Yakhteh), 2013, 15(Sup 1):45-46.
[24] Yamane K, Toumazou C, Tsukada Y, et al. JHDM2A, a JmjC-Containing H3K9 demethylase, facilitates transcription activation by androgen receptor[J]. Cell, 2006, 125(3):483-495.
[25] Suzuki T, Miyata N. Lysine demethylases inhibitors[J]. Journal of Medicinal Chemistry, 2011, 54(24):8236-8250.
[26] Nomura N, Nagase T, Miyajima N, et al. Prediction of the coding sequences of unidentified human genes[J]. OSA Publishing, 1995, 54(35):10443-10453. |